Oragenics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oragenics and other ETFs, options, and stocks.About OGEN
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains.
CEOJanet Huffman
CEOJanet Huffman
Employees3
Employees3
HeadquartersSarasota, Florida
HeadquartersSarasota, Florida
Founded1996
Founded1996
Employees3
Employees3
OGEN Key Statistics
Market cap3.88M
Market cap3.88M
Price-Earnings ratio-0.06
Price-Earnings ratio-0.06
Dividend yield—
Dividend yield—
Average volume74.40K
Average volume74.40K
High today$0.955
High today$0.955
Low today$0.9307
Low today$0.9307
Open price$0.944
Open price$0.944
Volume12.70K
Volume12.70K
52 Week high$18.90
52 Week high$18.90
52 Week low$0.82
52 Week low$0.82
Stock Snapshot
As of today, Oragenics(OGEN) shares are valued at $0.93. The company's market cap stands at 3.88M, with a P/E ratio of -0.06.
During the trading session on 2025-12-12, Oragenics(OGEN) shares reached a daily high of $0.96 and a low of $0.93. At a current price of $0.93, the stock is 0.0% higher than the low and still -2.5% under the high.
Trading activity shows a volume of 12.7K, compared to an average daily volume of 74.4K.
The stock's 52-week range extends from a low of $0.82 to a high of $18.90.
The stock's 52-week range extends from a low of $0.82 to a high of $18.90.
People also own
Based on the portfolios of people who own OGEN. This list is generated using Robinhood data, and it’s not a recommendation.